PLoS Pathogens (Mar 2023)

The anti-immune dengue subgenomic flaviviral RNA is present in vesicles in mosquito saliva and is associated with increased infectivity

  • Shih-Chia Yeh,
  • Tania Strilets,
  • Wei-Lian Tan,
  • David Castillo,
  • Hacène Medkour,
  • Félix Rey-Cadilhac,
  • Idalba M. Serrato-Pomar,
  • Florian Rachenne,
  • Avisha Chowdhury,
  • Vanessa Chuo,
  • Sasha R. Azar,
  • Moirangthem Kiran Singh,
  • Rodolphe Hamel,
  • Dorothée Missé,
  • R. Manjunatha Kini,
  • Linda J. Kenney,
  • Nikos Vasilakis,
  • Marc A. Marti-Renom,
  • Guy Nir,
  • Julien Pompon,
  • Mariano A. Garcia-Blanco

Journal volume & issue
Vol. 19, no. 3

Abstract

Read online

Mosquito transmission of dengue viruses to humans starts with infection of skin resident cells at the biting site. There is great interest in identifying transmission-enhancing factors in mosquito saliva in order to counteract them. Here we report the discovery of high levels of the anti-immune subgenomic flaviviral RNA (sfRNA) in dengue virus 2-infected mosquito saliva. We established that sfRNA is present in saliva using three different methods: northern blot, RT-qPCR and RNA sequencing. We next show that salivary sfRNA is protected in detergent-sensitive compartments, likely extracellular vesicles. In support of this hypothesis, we visualized viral RNAs in vesicles in mosquito saliva and noted a marked enrichment of signal from 3’UTR sequences, which is consistent with the presence of sfRNA. Furthermore, we show that incubation with mosquito saliva containing higher sfRNA levels results in higher virus infectivity in a human hepatoma cell line and human primary dermal fibroblasts. Transfection of 3’UTR RNA prior to DENV2 infection inhibited type I and III interferon induction and signaling, and enhanced viral replication. Therefore, we posit that sfRNA present in salivary extracellular vesicles is delivered to cells at the biting site to inhibit innate immunity and enhance dengue virus transmission. Author summary Mosquitoes transmit many viruses, such as those that cause dengue, introducing them in our bodies with the saliva that is deposited in our skins when they bite us. Scientists who study biting behavior and properties of mosquito saliva have concluded that there may be components in saliva that promote virus infection. In this study we show that when dengue virus infects mosquitoes one can find in their saliva not only the expected dengue viruses but also a dengue virus product that can reduce our anti-virus defense systems. It happens that this product is what is known as a non-coding RNA, a class of molecules that have recently been shown to mediate important biological regulation. We propose that by introducing this RNA at the biting site dengue infected saliva prepares the terrain for an efficient infection and gives the virus an advantage in the first battle between it and our immune defenses.